Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.56 |
| ▸ | ACACA | Q13085 | 3/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6882152 | 0.88 | ALDH1A1 (0.59) | LMNAALDH1A1TSHRRAB9AHSD17B10 | |
| SCHEMBL23244133 | 0.80 | LMNA (0.64) | ACACBACACALMNAALDH1A1TSHR | |
| SCHEMBL29576161 | 0.80 | LMNA (0.64) | ACACBACACALMNAALDH1A1TSHR | |
| SCHEMBL6187487 | 0.80 | KDM4E (0.51) | LMNAALDH1A1TSHRRAB9AKMT2A | |
| SCHEMBL18854912 | 0.78 | KMT2A (0.66) | LMNAALDH1A1TSHRRAB9AKMT2A | |
| SCHEMBL6229972 | 0.78 | ACACB (0.64) | ACACBACACALMNAALDH1A1TSHR | |
| SCHEMBL6231559 | 0.76 | USP2 (0.56) | ACACBACACALMNAALDH1A1TSHR | |
| SCHEMBL13257660 | 0.76 | ALDH1A1 (0.77) | LMNAALDH1A1TSHRRAB9AKMT2A | |
| SCHEMBL22096281 | 0.75 | FAAH (0.50) | LMNAALDH1A1KMT2AGAASMN1; SMN2 | |
| SCHEMBL5683016 | 0.75 | POLB (0.54) | LMNAALDH1A1TSHRHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1521748-A1 | NOVEL ANTHRACENE DERIVATIVES AND THE USE THEREOF AS A MEDICAMENT | Zentaris GmbH (DE) | 2005-04-13 | — | — | EP | claimed |
| US-20040110756-A1 | New anthracene derivatives and their use as pharmaceutical preparations | ZENTARIS GMBH (DE) | 2004-06-10 | — | — | US | claimed |
| WO-2004007470-A1 | NOVEL ANTHRACENE DERIVATIVES AND THE USE THEREOF AS A MEDICAMENT | ZENTARIS GMBH (DE) | 2004-01-22 | — | — | WO | claimed |
| EP-1521748-A1 | NOVEL ANTHRACENE DERIVATIVES AND THE USE THEREOF AS A MEDICAMENT | Zentaris GmbH (DE) | 2005-04-13 | — | — | EP | disclosed |
| US-20040110756-A1 | New anthracene derivatives and their use as pharmaceutical preparations | ZENTARIS GMBH (DE) | 2004-06-10 | — | — | US | disclosed |
| WO-2004007470-A1 | NOVEL ANTHRACENE DERIVATIVES AND THE USE THEREOF AS A MEDICAMENT | ZENTARIS GMBH (DE) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110756-A1 | New anthracene derivatives and their use as pharmaceutical preparations | CYP1A1, ANXA1, ANXA11 | ACACB 1387/4885ACACA 859/4885LMNA 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.